Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 11 - 29 tags : Covid save search
Omicron Variant has Vaccine Makers Moving Fast and More COVID News
Published: 2021-11-29 (Crawled : 21:00) - biospace.com/
JNJ | News | $144.86 0.06% 2.8M
|
Health Technology
|
| O: -0.7%
H: 0.0%
C: 0.0%
covid vaccine
BioReference Laboratories Announces Readiness for COVID-19 Testing if the Omicron COVID-19 Variant Emerges in The U.S.
Published: 2021-11-29 (Crawled : 20:00) - biospace.com/
OPK | $1.245 -0.4% 1.4M
|
Health Technology
|
| O: 0.24%
H: 2.9%
C: -1.21%
covid test merge covid-19
Valneva and IDT Biologika Announce Collaboration for Production of Inactivated COVID-19 Vaccine VLA2001
Published: 2021-11-29 (Crawled : 17:00) - globenewswire.com
IDT S | $36.4 1.76% 7.4K
|
Communications
|
| O: 1.78%
H: 0.0%
C: -4.23%
DVAX | $11.31 -1.05% 860K
|
Health Technology
|
| O: 2.82%
H: 1.97%
C: -4.23%
covid valneva vla200 collaboration vaccine vla2001 covid-19
Moderna COVID-19 vaccine effective 5 months after 2nd dose
Published: 2021-11-29 (Crawled : 16:00) - biospace.com/
MRNA | News S | $101.87 -1.52% 710K
|
Health Technology
|
| O: 12.35%
H: 1.71%
C: -0.49%
covid vaccine covid-19
Sorrento Publishes an Abivertinib Teaser Entitled “Abivertinib – A Franchise Oral Therapeutic for Cancer, COVID-19 and Autoimmune Diseases”
Published: 2021-11-29 (Crawled : 16:00) - biospace.com/
SRNE | $0.028 42K
|
Health Technology
|
| O: 3.87%
H: 0.0%
C: 0.0%
covid disease cancer
Cue Health Confirms COVID-19 Tests Can Detect Omicron Variant
Published: 2021-11-29 (Crawled : 15:30) - biospace.com/
HLTH | $0.148 2.35% 180K
|
|
| O: 2.71%
H: 1.19%
C: -5.02%
covid test covid-19 health
BetterLife Successfully Completes Phase 1 and Initiates Phase 2 Clinical Trials with Interferon Alpha-2b in COVID-19 Patients in Chile
Published: 2021-11-29 (Crawled : 15:00) - biospace.com/
BETRF | $0.077 34K
|
Health Technology
|
| O: -2.17%
H: 5.94%
C: -1.2%
phase 2 trials trial covid clinical trials phase 1
Co-Diagnostics, Inc. Reports that Suite of COVID-19 Diagnostics Not Affected by Heavily Mutated Omicron Variant
Published: 2021-11-29 (Crawled : 14:30) - biospace.com/
CODX | $1.15 0.88% 180K
|
Health Technology
|
| O: 5.75%
H: 0.89%
C: -8.01%
diagnostic diagnostics covid
Omicron Variant Underscores Need for New COVID Vaccine Candidates Like IBIO-202
Published: 2021-11-29 (Crawled : 14:00) - globenewswire.com
IBIO | $1.83 -3.18% 36K
|
Health Technology
|
| O: 5.45%
H: 0.0%
C: 0.0%
covid vaccine
Immunome Announces Submission of an Investigational New Drug (IND) Application for IMM-BCP-01 for the Treatment of COVID-19
Published: 2021-11-29 (Crawled : 12:30) - biospace.com/
IMNM | $17.825 2.56% 240K
|
Health Technology
|
| O: 7.88%
H: 13.26%
C: 12.55%
covid new drug treatment application drug submission
The Omicron Variant of SARS-CoV-2 has Minimal Impact on the T Cell Epitopes (Targets) Contained within Gritstone’s Self-Amplifying mRNA COVID-19 Vaccines
Published: 2021-11-29 (Crawled : 12:00) - globenewswire.com
GRTS | $0.7311 -1.89% 1.5M
|
Health Technology
|
| O: 2.95%
H: 0.66%
C: -7.28%
covid vaccine sars-cov-2 t-cell
Applied DNA Announces Strategy to Address Omicron SARS-CoV-2 Variant, Introduces Linea™ 2.0 COVID-19 Assay Kit
Published: 2021-11-29 (Crawled : 12:00) - biospace.com/
APDN | $0.35 5.1% 97K
|
Commercial Services
|
| O: 25.72%
H: 0.79%
C: -4.27%
covid sars-cov-2
DaVita Clinical Research Study Indicates Effectiveness of mRNA COVID-19 Vaccines in Dialysis Patients
Published: 2021-11-29 (Crawled : 12:00) - biospace.com/
DVA | $126.0 -1.29% 270K
|
Health Services
|
| O: -2.74%
H: 1.55%
C: -1.18%
covid vaccine research covid-19 dialysis
NRx Pharmaceuticals Identifies Significantly Higher Likelihood of Surviving and Recovering from Critical COVID-19 in ZYESAMI® (aviptadil) Treated Patients Previously Administered Remdesivir
Published: 2021-11-29 (Crawled : 12:00) - globenewswire.com
NRXP | News 0 d | $3.155 -24.52% 590K
|
Manufacturing
|
| O: 119.09%
H: 2.87%
C: -19.8%
zyesami covid aviptadil
Thermo Fisher Scientific Confirms Detection of SARS-CoV-2 in Samples Containing the Omicron Variant with its TaqPath COVID-19 Tests
Published: 2021-11-29 (Crawled : 06:00) - prnewswire.com
TMO | News | $542.71 -0.83% 1.2M
|
Health Technology
|
| O: -1.38%
H: 0.0%
C: 0.0%
covid test xin sars-cov-2
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
AGBA | $1.05 162.5% 100M
|
Finance
INVO | $1.36 78.95% 3.6M
|
Health Technology
BPTH | $5.62 73.46% 75M
|
Health Technology
TIRX | $0.8231 69.78% 54M
|
ISPC | $0.307 44.13% 3.6M
|
Professional, Scientific, and T...
SINT | $0.0519 39.14% 350M
|
Health Technology
XPON | $2.63 36.27% 8.4M
|
VTNR S | $1.26 28.68% 9.1M
|
Industrial Services
SWVL | $9.64 27.35% 200K
|
n/a
DFLI A | $0.7726 25.52% 4.3M
|
Your saved searches
Save your searches and get alerts when important news are released.